Related Experiment Video
Updated: Dec 6, 2025

07:54
Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
Published on: August 29, 2018
8.9K
Protocol for parallel proteomic and metabolomic analysis of mouse intervertebral disc tissues
Matthew A Veras1,2, Yong J Lim1, Miljan Kuljanin3
1Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry The University of Western Ontario London Ontario Canada.
JOR Spine
|October 5, 2020
Summary
This study presents a standardized protocol for parallel proteomic and metabolomic analysis of mouse intervertebral disc (IVD) tissues. This method optimizes small sample sizes for advancing chronic disease research.
Area of Science:
- Biochemistry
- Molecular Biology
- Biomedical Engineering
Background:
- Omics technologies offer comprehensive molecular insights into complex diseases.
- Standardized protocols are crucial for reproducible and comparable multi-group research findings.
- Musculoskeletal pathologies, like intervertebral disc (IVD) degeneration, require advanced molecular understanding.
Purpose of the Study:
- To describe a novel, standardized protocol for parallel proteomic and metabolomic analysis of murine intervertebral disc (IVD) tissues.
- To optimize "omics" applications using mouse models, addressing challenges of small sample size and tissue composition.
- To facilitate biomarker discovery and therapeutic target development for chronic diseases.
Main Methods:
- Detailed protocol for dissection of murine IVD tissues.
- Sample isolation techniques optimized for small tissue quantities.
- Integrated data analysis strategies for parallel proteomics and metabolomics.
Main Results:
- Successfully optimized a protocol for parallel omics analysis on limited murine IVD samples.
- Addressed challenges associated with small sample size and extracellular matrix-rich tissues.
- Established a reproducible method for comprehensive molecular profiling of IVD tissues.
Conclusions:
- The developed protocol enables robust parallel proteomic and metabolomic analysis of mouse IVD tissues.
- Standardization advances the application of omics technologies in musculoskeletal disease research.
- This method supports biomarker identification and therapeutic target development for chronic diseases.

